News & Updates

Most women with interstitial cystitis/bladder pain syndrome (IC/BPS) achieve a significant reduction in pelvic pain and dysuria following transvaginal photobiomodulation (TV-PBM), previously referred as low-level laser therapy, according to real-world data.

Oral midodrine may be a good alternative to intravenous albumin for preventing paracentesis-induced circulatory dysfunction (PICD) in patients with acute-on-chronic liver failure (ACLF) undergoing modest-volume paracentesis for ascites, suggests a new study.

A smoking cessation intervention, introduced as part of lung health screening, may encourage quitting in about 30 percent of smokers, results of the UK-based YESS* trial showed.

Monitoring of anti-Xa levels appears beneficial in evaluating current drug concentrations, ensuring immediate safety of therapy, and guiding possible clinical interventions, according to a study.

In the second interim analysis of the PEARLS/KEYNOTE-091 study, adjuvant pembrolizumab monotherapy provided a clinically meaningful improvement in disease-free survival (DFS) in individuals with stage IB–IIIA non-small cell lung cancer (NSCLC) after complete resection and adjuvant chemotherapy (CT).

New drug applications approved by US FDA as of 16 - 30 November 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.